#merck

[ follow ]
#earnings #keytruda #gardasil #guidance #pharmaceuticals #life-sciences-investment #uk-policy #verona-pharma
Healthcare
from24/7 Wall St.
1 day ago

Merck Reports Earnings Tuesday Morning After Gaining 13% Over the Past Year

Merck reports Q4 2025 earnings Feb. 3 before market; Street expects $2.01 EPS on $16.12B revenue; Keytruda, Gardasil, guidance and Verona integration are focus.
Medicine
fromwww.bbc.com
4 months ago

Blow for UK drugs sector as Merck scraps 1bn expansion

Merck is cancelling a planned £1bn UK life‑sciences expansion, relocating research to the US and cutting UK jobs, citing insufficient UK investment and undervaluation of innovative medicines.
fromMedCity News
6 months ago

Merck Breathes Life Into Its Respiratory Prospects With $10B Deal to Buy Verona Pharma - MedCity News

Merck has agreed to acquire Verona Pharma for $10 billion, gaining access to its first-in-class drug Ohtuvayre, which treats chronic obstructive pulmonary disease (COPD). This acquisition is crucial as Merck seeks assets amid an impending revenue drop from its top product losing patent protection.
Healthcare
[ Load more ]